| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.4171 |
| P8608 | Fatcat ID | release_7uswmfwmjzadli6u2bnuoixxfe |
| P932 | PMC publication ID | 3940725 |
| P698 | PubMed publication ID | 23338972 |
| P5875 | ResearchGate publication ID | 234824356 |
| P50 | author | Choladda V Curry | Q80852119 |
| P2093 | author name string | Lixia Diao | |
| Hesham M Amin | |||
| Haifeng Zhu | |||
| Deeksha Vishwamitra | |||
| Roxsan Manshouri | |||
| Aarish Khan | |||
| P2860 | cites work | ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) | Q24336482 |
| Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity | Q24522838 | ||
| Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB | Q24534564 | ||
| Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5) | Q24595848 | ||
| miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes | Q24596915 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. | Q24816506 | ||
| Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death | Q28202067 | ||
| Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma | Q28250347 | ||
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
| MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation | Q46599708 | ||
| Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent. | Q46915666 | ||
| Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. | Q54572569 | ||
| IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. | Q54788828 | ||
| Nitric oxide signaling: a possible role for G proteins | Q72651333 | ||
| Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells | Q73316158 | ||
| Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas | Q73937573 | ||
| Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels | Q28368070 | ||
| Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation | Q28585425 | ||
| Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth | Q30156817 | ||
| Ubiquitination of inducible nitric oxide synthase is required for its degradation | Q34155970 | ||
| Loss of inducible nitric oxide synthase expression in the mouse renal cell carcinoma cell line RENCA is mediated by microRNA miR-146a | Q34162507 | ||
| Role of nitric oxide in carcinogenesis and tumour progression | Q34570058 | ||
| MicroRNA expression profiling using microarrays | Q34767925 | ||
| DNA deaminating ability and genotoxicity of nitric oxide and its progenitors | Q34983829 | ||
| The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. | Q35851325 | ||
| MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression | Q35951821 | ||
| Pathobiology of ALK+ anaplastic large-cell lymphoma | Q36007756 | ||
| Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma | Q36065849 | ||
| Calmodulin is a subunit of nitric oxide synthase from macrophages | Q36231600 | ||
| Assays for nitric oxide expression. | Q36234664 | ||
| The role of nitric oxide in tumour progression | Q36516414 | ||
| The anaplastic lymphoma kinase in the pathogenesis of cancer | Q37039605 | ||
| iNOS as a therapeutic target for treatment of human tumors | Q37178499 | ||
| Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer | Q37198891 | ||
| IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells | Q37271044 | ||
| The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling | Q38299315 | ||
| Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target | Q38326252 | ||
| Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer | Q38458827 | ||
| miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. | Q39449882 | ||
| MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression | Q39562983 | ||
| Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells | Q39947779 | ||
| Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway | Q40410769 | ||
| iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: mechanism of cell survival in solid tumor core | Q40420785 | ||
| Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene | Q40444994 | ||
| Inducible nitric oxide synthase-mediated proliferation of a T lymphoma cell line. | Q40666204 | ||
| Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway | Q40838398 | ||
| The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts. | Q41086595 | ||
| B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. | Q42458757 | ||
| Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation | Q42833922 | ||
| Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. | Q42835098 | ||
| Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma | Q43665317 | ||
| NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. | Q44211040 | ||
| Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions | Q44628915 | ||
| The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells | Q44772804 | ||
| P433 | issue | 1 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 82-94 | |
| P577 | publication date | 2013-03-14 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism | |
| P478 | volume | 230 |
| Q38184584 | ALK-positive cancer: still a growing entity. |
| Q41786278 | Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations. |
| Q38644718 | Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas |
| Q38190915 | Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias |
| Q37690218 | Leishmania (Leishmania) amazonensis induces macrophage miR-294 and miR-721 expression and modulates infection by targeting NOS2 and L-arginine metabolism. |
| Q47762719 | MiR-26a functions as a tumor suppressor in ambient particulate matter-bound metal-triggered lung cancer cell metastasis by targeting LIN28B-IL6-STAT3 axis |
| Q92258573 | Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis |
| Q64064052 | The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance |
| Q35556180 | The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma |
| Q86893123 | microRNA in Malignant Lymphoma |
| Q36741352 | microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production |
Search more.